EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Germline Profiling of High-Grade Serous Ovarian Cancer Using Whole-Exome Sequencing

Hye-Lim Cho iD, Seong Eun Bak iD, Mi-Ryung Han, Youn Jin Choi iD

International Journal of Molecular Sciences · 19.06.2026 · 27 (12) · 5564

DOI: 10.3390/ijms27125564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.06.2026. Verfasst von Hye-Lim Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22014, Republic of Korea. Hauptthemen laut MEDLINE: Germ-Line Mutation, Ovarian Neoplasms, Exome Sequencing, Cystadenocarcinoma, Serous. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National R&D Program for Cancer Control through the National Cancer Center (NCC) and the Ministry of Health & Welfare, Republic of Korea, The National Research Foundation of Korea (NRF), National Cancer Center (NCC) and the Ministry of Health & Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While ovarian cancer screening is not recommended in the general population, attention has shifted to screening women with elevated hereditary risks. Although germline BRCA 1/2 pathogenic variants account for 40% of inherited ovarian cancer risk and family history (FH) remains important, known germline variants alone do not fully explain familial ovarian cancer risk. Whole-exome sequencing (WES) was performed on blood samples taken from 231 individuals, including 39 patients with high-grade serous ovarian cancer (HGSOC) and 192 healthy controls (HCs) stratified by FH. We analyzed pathogenic or likely pathogenic (P/LP) germline variants in cancer-related genes and assessed their association with family cancer history. Additionally, we performed somatic variant comparisons using 1:4 propensity score matching and analyzed clonal hematopoiesis of indeterminate potential (CHIP)-related somatic variants. P/LP germline variants were detected in 56.4% of HGSOC patients, 49.4% of controls with FH, and 33.3% without. The HGSOC group and controls with FH exhibited similar P/LP germline mutation patterns in ovarian cancer-related genes. From CHIP analysis, somatic CHIP mutations were detected in 6.3% of the HGSOC group and 8.5% in HCs. Our findings demonstrate genomic overlap between ovarian cancer patients and FH-positive individuals. Therefore, germline variant screening could be considered to facilitate early diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationOvarian NeoplasmsExome SequencingCystadenocarcinoma, SerousHumansFemaleMiddle AgedGenetic Predisposition to DiseaseAgedAdultNeoplasm GradingCase-Control Studies

Stichwörter der Autor:innen

clonal hematopoiesisfamily historygermline variantshereditary breast and ovarian cancerhigh-grade serous ovarian cancerpropensity score matchingscreeningsomatic variantswhole-exome sequencing

Autor:innen und Institutionen

  • Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22014, Republic of Korea.
  • Department of Obstetrics and Gynecology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Institute for New Drug Development, College of Life Science and Bioengineering, Incheon National University, Incheon 22014, Republic of Korea.
  • Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

ORCID-Profile: Hye-Lim Cho, Seong Eun Bak, Youn Jin Choi

Förderung

  • The National R&D Program for Cancer Control through the National Cancer Center (NCC) and the Ministry of Health & Welfare, Republic of Korea
  • The National Research Foundation of Korea (NRF)
  • National Cancer Center (NCC) and the Ministry of Health & Welfare

Zitieren

APA

Cho, H. L., Bak, S. E., Han, M. R., & Choi, Y. J. (2026). Comprehensive Germline Profiling of High-Grade Serous Ovarian Cancer Using Whole-Exome Sequencing. International Journal of Molecular Sciences, 27(12), 5564. https://doi.org/10.3390/ijms27125564

Vancouver

Cho HL, Bak SE, Han MR, Choi YJ. Comprehensive Germline Profiling of High-Grade Serous Ovarian Cancer Using Whole-Exome Sequencing. International Journal of Molecular Sciences. 2026;27(12):5564. doi:10.3390/ijms27125564

BibTeX
@article{Cho2026,
  author = {Cho, Hye-Lim and Bak, Seong Eun and Han, Mi-Ryung and Choi, Youn Jin},
  title = {Comprehensive Germline Profiling of High-Grade Serous Ovarian Cancer Using Whole-Exome Sequencing},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5564},
  doi = {10.3390/ijms27125564}
}
Kostenlos starten →